Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2005
05/12/2005WO2005042781A2 Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof
05/12/2005WO2005042780A1 Phage antibodies to radiation-inducible neoantigens
05/12/2005WO2005042778A1 Using nucleic acids for clinical microbiology testing
05/12/2005WO2005042776A1 Method of determining predisposition towards atherosclerosis
05/12/2005WO2005042775A1 Short biological polymers on solid supports
05/12/2005WO2005042773A1 Methods and compositions for identifying therapeutic compounds
05/12/2005WO2005042772A1 Methods and compositions for identifying therapeutic compounds
05/12/2005WO2005042771A2 Colorimetric substrates, colorimetric sensors, and methods of use
05/12/2005WO2005042770A2 Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
05/12/2005WO2005042769A1 Methods for inducing complete apoptosis of liver cells expressing hbx protein and screening for substances or genes that inhibit the apoptosis
05/12/2005WO2005042767A2 Compositions and methods for detecting severe acute respiratory syndrome coronavirus
05/12/2005WO2005042764A2 Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles
05/12/2005WO2005042763A2 Optimization of gene expression analysis using immobilized capture probes
05/12/2005WO2005042762A2 Lrpap1 genetic markers associated with galantamine response
05/12/2005WO2005042760A2 Systems and methods for detecting biological features
05/12/2005WO2005042759A2 Expression profiling using microarrays
05/12/2005WO2005042746A1 Bacterial virulence factors and uses thereof
05/12/2005WO2005042734A1 Ser/thr kinase involved in autophagocytosis as a target for fungicides
05/12/2005WO2005042733A1 Hbv variants detection and application
05/12/2005WO2005042725A2 Liver cancer biomarkers
05/12/2005WO2005042716A2 Nucleic acid binding oligonucleotides
05/12/2005WO2005042715A2 Angiogensis models using nestin-expressing stem cells to image nascent blood vessels
05/12/2005WO2005042713A2 Quantitative multiplex methylation-specific pcr
05/12/2005WO2005042709A2 Compositions, methods and detection technologies for reiterative oligonucleotide synthesis
05/12/2005WO2005042706A2 Ephx2 genetic markers associated with galantamine response
05/12/2005WO2005042704A2 Differential enzymatic fragmentation
05/12/2005WO2005042701A2 Methods to identify compounds useful for tumor sensitization to dna damage
05/12/2005WO2005042695A2 Lipoparticles comprising proteins, methods of making, and using the same
05/12/2005WO2005042578A2 Antibody fab fragment specific for breast cancer
05/12/2005WO2005042576A1 Clq RELATED PROTEIN
05/12/2005WO2005042574A1 High troughput functional assay for g-protein coupled receptors using a rap-ras chimeric protein
05/12/2005WO2005042570A1 Hcv ns3-ns4a protease resistance mutants
05/12/2005WO2005042552A2 Modulation of sglt2 expression
05/12/2005WO2005042504A1 Fluorinated resorufin compounds and their application in detecting hydrogen peroxide
05/12/2005WO2005042146A2 Apparatus and method for dispensing fluid, semi-solid and solid samples
05/12/2005WO2005042002A2 Treatment of rhematoid arthritis with flip antagonists
05/12/2005WO2005041903A2 Methods and reagents for diagnosis and treatment of diabetes
05/12/2005WO2005041896A2 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke
05/12/2005WO2005041880A2 RhPV AS A MODEL FOR HPV-INDUCED CANCERS
05/12/2005WO2005041750A2 Method for identifying compounds that affect expression of tryptophan hydroxylase isoform 2
05/12/2005WO2005026192A3 Hpv cd8+ t-cell epitopes
05/12/2005WO2005024418A3 Novel markers for alternatively activated macrophages
05/12/2005WO2005022143A3 Method and apparatus for assay of electrochemical properties
05/12/2005WO2005021777A3 Uses of spatial configuration to modulate protein function
05/12/2005WO2005021731A3 Soluble analyte detection and amplification
05/12/2005WO2005019249A8 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
05/12/2005WO2005007883A3 Method for detecting and/or identifying bacteria of genus staphylococcus
05/12/2005WO2005005662A3 Secreted proteins as markers for cell differentiation
05/12/2005WO2005005596A3 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof
05/12/2005WO2005003766A3 Methods of regulating metabolism and mitochondrial function
05/12/2005WO2005001132A3 Gene expression profiles that identify genetically elite ungulate mammals
05/12/2005WO2004113556A8 Assay and kits for detecting protein binding
05/12/2005WO2004111606A3 Automated microbiological testing apparatus and method
05/12/2005WO2004106887A3 Quality assurance/quality control for high throughput bioassay process
05/12/2005WO2004106497A3 Imageable animal model of sars infection
05/12/2005WO2004104172A3 Hybridization-mediated analysis of polymorphisms
05/12/2005WO2004102149A3 Methods and compositions for the detection of bacterial species
05/12/2005WO2004098386A3 Oligonucleotides comprising a molecular switch
05/12/2005WO2004097029A3 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
05/12/2005WO2004092324A3 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
05/12/2005WO2004090164A3 Method for determining soil condition
05/12/2005WO2004083403A3 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
05/12/2005WO2004081183A3 In vitro dna immortalization and whole genome amplification using libraries generated from randomly fragmented dna
05/12/2005WO2004068115A3 Assay method for group transfer reactions
05/12/2005WO2004064710A3 Applications of substances binding to gstm for the diagnosis and treatment of cystic carcinomas
05/12/2005WO2004050835A3 Predicting animal performance
05/12/2005WO2004044137A3 Modified oligomeric compounds and compositions for use in gene modulation
05/12/2005WO2004040014A9 Gene expression in biological conditions
05/12/2005WO2004029284A3 Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes
05/12/2005WO2004029281A3 Methods and compositions for rnai mediated inhibition of viral gene expression in mammals
05/12/2005WO2004022775A8 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
05/12/2005WO2004018642A3 Methods for detecting genes associated with bone properties and/or height
05/12/2005WO2004009807A8 Two-phase alcohol dehydrogenase-based coupled enzymatic reaction system
05/12/2005WO2003091695A3 Identification of biomarkers for detecting prostate cancer
05/12/2005WO2003085124A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/12/2005WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
05/12/2005US20050102713 Expression vector comprising regulatory sequences associated with expression of antifungal protein for use as tool in generating transgenic plants with enhanced exogeneous gene transcription and insect and herbicide resistance
05/12/2005US20050102712 Using chlorophyll biosynthesis enzyme as tool for identifying agents which enhance photosynthetic activity of plants
05/12/2005US20050102106 Diagnostic method for assessing a condition of a performance animal
05/12/2005US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents
05/12/2005US20050101771 Used in clinical examinations and can precisely assay glycated proteins
05/12/2005US20050101769 CD40-interacting and TRAF-interacting proteins
05/12/2005US20050101619 Viricide found from high-throughput cell-free assay that rapidly screen libraries of compounds for viral-capsid binding activity; 1,4-dimercapto-2-butene S,S'-substituted with a benzothiazole, a pyrimidine, or a imidazole ring; NOTE claims are only for a Markush compound; no screening process is claimed
05/12/2005US20050101557 Immunostimulatory nucleic acid molecules
05/12/2005US20050101556 Genetic engineering; Alzheimer's disease; anticancer agents
05/12/2005US20050101554 Methods for treating and preventing infectious disease
05/12/2005US20050101536 Modulation of angiogenesis
05/12/2005US20050101530 Cellular virus receptors and methods of use
05/12/2005US20050101529 Protein modification and maintenance molecules
05/12/2005US20050101485 Methods for the identification of inhibitors of biotin synthase expression or activity in plants
05/12/2005US20050101019 Method and device for targeted delivery of materials to selected single cells
05/12/2005US20050101014 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
05/12/2005US20050101004 Screening for a compound to inhibit the urge for urinary incontinence by detecting activation of KCNQ protein in the host cell; measuring the membrane potential of the host cell and selecting the compound whose presence causes hyperpolarization in themembrane potential of the host cell
05/12/2005US20050100985 Saturation mutagenesis in directed evolution
05/12/2005US20050100980 Using statistical analysis and absortion specta as tools identification of microorganisms
05/12/2005US20050100979 Using non-selenium glutathione peroxidase protein concentrations as diagnostic/prognostic tool in detection of neurodegenerative disorders
05/12/2005US20050100978 Nitropyrimidine derivative for detection and evaluation of kinase inhibitors
05/12/2005US20050100977 Biochemical sensing device
05/12/2005US20050100973 Using synaptosomal associated protein-25 (SNAP-25) as tool to screen for clostridial toxin protease activity; food safety; detecting food poisoning
05/12/2005US20050100972 Use of grf1 protein for screening molecules